Global Telmisartan Market Growth 2020-2025

Publisher Name :
Date: 25-Nov-2020
No. of pages: 161

According to this study, over the next five years the Telmisartan market will register a 0.8%% CAGR in terms of revenue, the global market size will reach $ 3356.8 million by 2025, from $ 3248.5 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Telmisartan business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Telmisartan market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Telmisartan, covering the supply chain analysis, impact assessment to the Telmisartan market size growth rate in several scenarios, and the measures to be undertaken by Telmisartan companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

- Injection

- Freeze-Dried Powder

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

- Hospital

- Clinic

- Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Pfizer

- Astellas Pharma Inc

- Teva

- Novartis

- Mylan

- Boehringer Ingelheim

- Bayer

- Reddy's Laboratories (UK)

- GSK

- Hema Pharmaceuticals Pvt

- Nippon Boehringer Ingelheim

- Beijing Wansheng Pharmaceutical

- Takeda

- Abbott

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Telmisartan consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Telmisartan market by identifying its various subsegments.

- Focuses on the key global Telmisartan manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Telmisartan with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Telmisartan submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Telmisartan Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Telmisartan Consumption 2015-2025
2.1.2 Telmisartan Consumption CAGR by Region
2.2 Telmisartan Segment by Type
2.2.1 Injection
2.2.2 Freeze-Dried Powder
2.3 Telmisartan Consumption by Type
2.3.1 Global Telmisartan Consumption Market Share by Type (2015-2020)
2.3.2 Global Telmisartan Revenue and Market Share by Type (2015-2020)
2.3.3 Global Telmisartan Sale Price by Type (2015-2020)
2.4 Telmisartan Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Telmisartan Consumption by Application
2.5.1 Global Telmisartan Consumption Market Share by Type (2015-2020)
2.5.2 Global Telmisartan Value and Market Share by Type (2015-2020)
2.5.3 Global Telmisartan Sale Price by Type (2015-2020)

3 Global Telmisartan by Company
3.1 Global Telmisartan Sales Market Share by Company
3.1.1 Global Telmisartan Sales by Company (2018-2020)
3.1.2 Global Telmisartan Sales Market Share by Company (2018-2020)
3.2 Global Telmisartan Revenue Market Share by Company
3.2.1 Global Telmisartan Revenue by Company (2018-2020)
3.2.2 Global Telmisartan Revenue Market Share by Company (2018-2020)
3.3 Global Telmisartan Sale Price by Company
3.4 Global Telmisartan Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Telmisartan Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Telmisartan Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Telmisartan by Regions
4.1 Telmisartan by Regions
4.2 Americas Telmisartan Consumption Growth
4.3 APAC Telmisartan Consumption Growth
4.4 Europe Telmisartan Consumption Growth
4.5 Middle East & Africa Telmisartan Consumption Growth

5 Americas
5.1 Americas Telmisartan Consumption by Countries
5.1.1 Americas Telmisartan Consumption by Countries (2015-2020)
5.1.2 Americas Telmisartan Value by Countries (2015-2020)
5.2 Americas Telmisartan Consumption by Type
5.3 Americas Telmisartan Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Telmisartan Consumption by Regions
6.1.1 APAC Telmisartan Consumption by Regions (2015-2020)
6.1.2 APAC Telmisartan Value by Regions (2015-2020)
6.2 APAC Telmisartan Consumption by Type
6.3 APAC Telmisartan Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Telmisartan by Countries
7.1.1 Europe Telmisartan Consumption by Countries (2015-2020)
7.1.2 Europe Telmisartan Value by Countries (2015-2020)
7.2 Europe Telmisartan Consumption by Type
7.3 Europe Telmisartan Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Telmisartan by Countries
8.1.1 Middle East & Africa Telmisartan Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Telmisartan Value by Countries (2015-2020)
8.2 Middle East & Africa Telmisartan Consumption by Type
8.3 Middle East & Africa Telmisartan Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Telmisartan Distributors
10.3 Telmisartan Customer

11 Global Telmisartan Market Forecast
11.1 Global Telmisartan Consumption Forecast (2021-2025)
11.2 Global Telmisartan Forecast by Regions
11.2.1 Global Telmisartan Forecast by Regions (2021-2025)
11.2.2 Global Telmisartan Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Telmisartan Forecast by Type
11.8 Global Telmisartan Forecast by Application

12 Key Players Analysis
12.1 Pfizer
12.1.1 Company Information
12.1.2 Telmisartan Product Offered
12.1.3 Pfizer Telmisartan Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Pfizer Latest Developments
12.2 Astellas Pharma Inc
12.2.1 Company Information
12.2.2 Telmisartan Product Offered
12.2.3 Astellas Pharma Inc Telmisartan Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Astellas Pharma Inc Latest Developments
12.3 Teva
12.3.1 Company Information
12.3.2 Telmisartan Product Offered
12.3.3 Teva Telmisartan Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Teva Latest Developments
12.4 Novartis
12.4.1 Company Information
12.4.2 Telmisartan Product Offered
12.4.3 Novartis Telmisartan Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Novartis Latest Developments
12.5 Mylan
12.5.1 Company Information
12.5.2 Telmisartan Product Offered
12.5.3 Mylan Telmisartan Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Mylan Latest Developments
12.6 Boehringer Ingelheim
12.6.1 Company Information
12.6.2 Telmisartan Product Offered
12.6.3 Boehringer Ingelheim Telmisartan Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Boehringer Ingelheim Latest Developments
12.7 Bayer
12.7.1 Company Information
12.7.2 Telmisartan Product Offered
12.7.3 Bayer Telmisartan Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Bayer Latest Developments
12.8 Reddy's Laboratories (UK)
12.8.1 Company Information
12.8.2 Telmisartan Product Offered
12.8.3 Reddy's Laboratories (UK) Telmisartan Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Reddy's Laboratories (UK) Latest Developments
12.9 GSK
12.9.1 Company Information
12.9.2 Telmisartan Product Offered
12.9.3 GSK Telmisartan Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 GSK Latest Developments
12.10 Hema Pharmaceuticals Pvt
12.10.1 Company Information
12.10.2 Telmisartan Product Offered
12.10.3 Hema Pharmaceuticals Pvt Telmisartan Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Hema Pharmaceuticals Pvt Latest Developments
12.11 Nippon Boehringer Ingelheim
12.11.1 Company Information
12.11.2 Telmisartan Product Offered
12.11.3 Nippon Boehringer Ingelheim Telmisartan Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Nippon Boehringer Ingelheim Latest Developments
12.12 Beijing Wansheng Pharmaceutical
12.12.1 Company Information
12.12.2 Telmisartan Product Offered
12.12.3 Beijing Wansheng Pharmaceutical Telmisartan Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Beijing Wansheng Pharmaceutical Latest Developments
12.13 Takeda
12.13.1 Company Information
12.13.2 Telmisartan Product Offered
12.13.3 Takeda Telmisartan Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Takeda Latest Developments
12.14 Abbott
12.14.1 Company Information
12.14.2 Telmisartan Product Offered
12.14.3 Abbott Telmisartan Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Abbott Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Telmisartan Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Injection
Table 5. Major Players of Freeze-Dried Powder
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Telmisartan Consumption Market Share by Type (2015-2020)
Table 8. Global Telmisartan Revenue by Type (2015-2020) ($ million)
Table 9. Global Telmisartan Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Telmisartan Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Telmisartan Consumption Market Share by Application (2015-2020)
Table 13. Global Telmisartan Value by Application (2015-2020)
Table 14. Global Telmisartan Value Market Share by Application (2015-2020)
Table 15. Global Telmisartan Sale Price by Application (2015-2020)
Table 16. Global Telmisartan Sales by Company (2017-2019) (MT)
Table 17. Global Telmisartan Sales Market Share by Company (2017-2019)
Table 18. Global Telmisartan Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Telmisartan Revenue Market Share by Company (2017-2019)
Table 20. Global Telmisartan Sale Price by Company (2017-2019)
Table 21. Global Telmisartan Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Telmisartan Products Offered
Table 23. Telmisartan Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Telmisartan Consumption by Regions 2015-2020 (MT)
Table 25. Global Telmisartan Consumption Market Share by Regions 2015-2020
Table 26. Global Telmisartan Value by Regions 2015-2020 ($ Millions)
Table 27. Global Telmisartan Value Market Share by Regions 2015-2020
Table 28. Americas Telmisartan Consumption by Countries (2015-2020) (MT)
Table 29. Americas Telmisartan Consumption Market Share by Countries (2015-2020)
Table 30. Americas Telmisartan Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Telmisartan Value Market Share by Countries (2015-2020)
Table 32. Americas Telmisartan Consumption by Type (2015-2020) (MT)
Table 33. Americas Telmisartan Consumption Market Share by Type (2015-2020)
Table 34. Americas Telmisartan Consumption by Application (2015-2020) (MT)
Table 35. Americas Telmisartan Consumption Market Share by Application (2015-2020)
Table 36. APAC Telmisartan Consumption by Regions (2015-2020) (MT)
Table 37. APAC Telmisartan Consumption Market Share by Regions (2015-2020)
Table 38. APAC Telmisartan Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Telmisartan Value Market Share by Regions (2015-2020)
Table 40. APAC Telmisartan Consumption by Type (2015-2020) (MT)
Table 41. APAC Telmisartan Consumption Market Share by Type (2015-2020)
Table 42. APAC Telmisartan Consumption by Application (2015-2020) (MT)
Table 43. APAC Telmisartan Consumption Market Share by Application (2015-2020)
Table 44. Europe Telmisartan Consumption by Countries (2015-2020) (MT)
Table 45. Europe Telmisartan Consumption Market Share by Countries (2015-2020)
Table 46. Europe Telmisartan Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Telmisartan Value Market Share by Countries (2015-2020)
Table 48. Europe Telmisartan Consumption by Type (2015-2020) (MT)
Table 49. Europe Telmisartan Consumption Market Share by Type (2015-2020)
Table 50. Europe Telmisartan Consumption by Application (2015-2020) (MT)
Table 51. Europe Telmisartan Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Telmisartan Consumption by Countries (2015-2020) (MT)
Table 53. Middle East & Africa Telmisartan Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Telmisartan Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Telmisartan Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Telmisartan Consumption by Type (2015-2020) (MT)
Table 57. Middle East & Africa Telmisartan Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Telmisartan Consumption by Application (2015-2020) (MT)
Table 59. Middle East & Africa Telmisartan Consumption Market Share by Application (2015-2020)
Table 60. Telmisartan Distributors List
Table 61. Telmisartan Customer List
Table 62. Global Telmisartan Consumption Forecast by Countries (2021-2025) (MT)
Table 63. Global Telmisartan Consumption Market Forecast by Regions
Table 64. Global Telmisartan Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Telmisartan Value Market Share Forecast by Regions
Table 66. Global Telmisartan Consumption Forecast by Type (2021-2025) (MT)
Table 67. Global Telmisartan Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Telmisartan Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Telmisartan Value Market Share Forecast by Type (2021-2025)
Table 70. Global Telmisartan Consumption Forecast by Application (2021-2025) (MT)
Table 71. Global Telmisartan Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Telmisartan Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Telmisartan Value Market Share Forecast by Application (2021-2025)
Table 74. Pfizer Product Offered
Table 75. Pfizer Telmisartan Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 76. Pfizer Main Business
Table 77. Pfizer Latest Developments
Table 78. Pfizer Basic Information, Company Total Revenue (in $ million), Telmisartan Manufacturing Base, Sales Area and Its Competitors
Table 79. Astellas Pharma Inc Product Offered
Table 80. Astellas Pharma Inc Telmisartan Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 81. Astellas Pharma Inc Main Business
Table 82. Astellas Pharma Inc Latest Developments
Table 83. Astellas Pharma Inc Basic Information, Company Total Revenue (in $ million), Telmisartan Manufacturing Base, Sales Area and Its Competitors
Table 84. Teva Product Offered
Table 85. Teva Telmisartan Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 86. Teva Main Business
Table 87. Teva Latest Developments
Table 88. Teva Basic Information, Company Total Revenue (in $ million), Telmisartan Manufacturing Base, Sales Area and Its Competitors
Table 89. Novartis Product Offered
Table 90. Novartis Telmisartan Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 91. Novartis Main Business
Table 92. Novartis Latest Developments
Table 93. Novartis Basic Information, Company Total Revenue (in $ million), Telmisartan Manufacturing Base, Sales Area and Its Competitors
Table 94. Mylan Product Offered
Table 95. Mylan Telmisartan Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 96. Mylan Main Business
Table 97. Mylan Latest Developments
Table 98. Mylan Basic Information, Company Total Revenue (in $ million), Telmisartan Manufacturing Base, Sales Area and Its Competitors
Table 99. Boehringer Ingelheim Product Offered
Table 100. Boehringer Ingelheim Telmisartan Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 101. Boehringer Ingelheim Main Business
Table 102. Boehringer Ingelheim Latest Developments
Table 103. Boehringer Ingelheim Basic Information, Company Total Revenue (in $ million), Telmisartan Manufacturing Base, Sales Area and Its Competitors
Table 104. Bayer Product Offered
Table 105. Bayer Basic Information, Company Total Revenue (in $ million), Telmisartan Manufacturing Base, Sales Area and Its Competitors
Table 106. Bayer Main Business
Table 107. Bayer Latest Developments
Table 108. Bayer Telmisartan Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 109. Reddy's Laboratories (UK) Product Offered
Table 110. Reddy's Laboratories (UK) Telmisartan Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 111. Reddy's Laboratories (UK) Main Business
Table 112. Reddy's Laboratories (UK) Latest Developments
Table 113. Reddy's Laboratories (UK) Basic Information, Company Total Revenue (in $ million), Telmisartan Manufacturing Base, Sales Area and Its Competitors
Table 114. GSK Product Offered
Table 115. GSK Telmisartan Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 116. GSK Main Business
Table 117. GSK Latest Developments
Table 118. GSK Basic Information, Company Total Revenue (in $ million), Telmisartan Manufacturing Base, Sales Area and Its Competitors
Table 119. Hema Pharmaceuticals Pvt Product Offered
Table 120. Hema Pharmaceuticals Pvt Telmisartan Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 121. Hema Pharmaceuticals Pvt Main Business
Table 122. Hema Pharmaceuticals Pvt Latest Developments
Table 123. Hema Pharmaceuticals Pvt Basic Information, Company Total Revenue (in $ million), Telmisartan Manufacturing Base, Sales Area and Its Competitors
Table 124. Nippon Boehringer Ingelheim Product Offered
Table 125. Nippon Boehringer Ingelheim Telmisartan Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 126. Nippon Boehringer Ingelheim Main Business
Table 127. Nippon Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. Nippon Boehringer Ingelheim Latest Developments
Table 129. Beijing Wansheng Pharmaceutical Product Offered
Table 130. Beijing Wansheng Pharmaceutical Telmisartan Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 131. Beijing Wansheng Pharmaceutical Main Business
Table 132. Beijing Wansheng Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Beijing Wansheng Pharmaceutical Latest Developments
Table 134. Takeda Product Offered
Table 135. Takeda Telmisartan Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 136. Takeda Main Business
Table 137. Takeda Latest Developments
Table 138. Takeda Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 139. Abbott Product Offered
Table 140. Abbott Telmisartan Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 141. Abbott Main Business
Table 142. Abbott Latest Developments
Table 143. Abbott Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Telmisartan
Figure 2. Telmisartan Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Telmisartan Consumption Growth Rate 2015-2025 (MT)
Figure 5. Global Telmisartan Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Injection
Figure 7. Product Picture of Freeze-Dried Powder
Figure 8. Global Telmisartan Consumption Market Share by Type (2015-2020)
Figure 9. Global Telmisartan Value Market Share by Type (2015-2020)
Figure 10. Telmisartan Consumed in Hospital
Figure 11. Global Telmisartan Market: Hospital (2015-2020) (MT)
Figure 12. Global Telmisartan Market: Hospital (2015-2020) ($ Millions)
Figure 13. Telmisartan Consumed in Clinic
Figure 14. Global Telmisartan Market: Clinic (2015-2020) (MT)
Figure 15. Global Telmisartan Market: Clinic (2015-2020) ($ Millions)
Figure 16. Telmisartan Consumed in Others
Figure 17. Global Telmisartan Market: Others (2015-2020) (MT)
Figure 18. Global Telmisartan Market: Others (2015-2020) ($ Millions)
Figure 19. Global Telmisartan Consumption Market Share by Application (2015-2020)
Figure 20. Global Telmisartan Value Market Share by Application (2015-2020)
Figure 21. Global Telmisartan Sales Market Share by Company in 2017
Figure 22. Global Telmisartan Sales Market Share by Company in 2019
Figure 23. Global Telmisartan Revenue Market Share by Company in 2017
Figure 24. Global Telmisartan Revenue Market Share by Company in 2019
Figure 25. Global Telmisartan Sale Price by Company in 2019
Figure 26. Global Telmisartan Consumption Market Share by Regions 2015-2020
Figure 27. Global Telmisartan Value Market Share by Regions 2015-2020
Figure 28. Americas Telmisartan Consumption 2015-2020 (MT)
Figure 29. Americas Telmisartan Value 2015-2020 ($ Millions)
Figure 30. APAC Telmisartan Consumption 2015-2020 (MT)
Figure 31. APAC Telmisartan Value 2015-2020 ($ Millions)
Figure 32. Europe Telmisartan Consumption 2015-2020 (MT)
Figure 33. Europe Telmisartan Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Telmisartan Consumption 2015-2020 (MT)
Figure 35. Middle East & Africa Telmisartan Value 2015-2020 ($ Millions)
Figure 36. Americas Telmisartan Consumption Market Share by Countries in 2019
Figure 37. Americas Telmisartan Value Market Share by Countries in 2019
Figure 38. Americas Telmisartan Consumption Market Share by Type in 2019
Figure 39. Americas Telmisartan Consumption Market Share by Application in 2019
Figure 40. United States Telmisartan Consumption Growth 2015-2020 (MT)
Figure 41. United States Telmisartan Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Telmisartan Consumption Growth 2015-2020 (MT)
Figure 43. Canada Telmisartan Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Telmisartan Consumption Growth 2015-2020 (MT)
Figure 45. Mexico Telmisartan Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Telmisartan Consumption Market Share by Countries in 2019
Figure 47. APAC Telmisartan Value Market Share by Regions in 2019
Figure 48. APAC Telmisartan Consumption Market Share by Type in 2019
Figure 49. APAC Telmisartan Consumption Market Share by Application in 2019
Figure 50. China Telmisartan Consumption Growth 2015-2020 (MT)
Figure 51. China Telmisartan Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Telmisartan Consumption Growth 2015-2020 (MT)
Figure 53. Japan Telmisartan Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Telmisartan Consumption Growth 2015-2020 (MT)
Figure 55. Korea Telmisartan Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Telmisartan Consumption Growth 2015-2020 (MT)
Figure 57. Southeast Asia Telmisartan Value Growth 2015-2020 ($ Millions)
Figure 58. India Telmisartan Consumption Growth 2015-2020 (MT)
Figure 59. India Telmisartan Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Telmisartan Consumption Growth 2015-2020 (MT)
Figure 61. Australia Telmisartan Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Telmisartan Consumption Market Share by Countries in 2019
Figure 63. Europe Telmisartan Value Market Share by Countries in 2019
Figure 64. Europe Telmisartan Consumption Market Share by Type in 2019
Figure 65. Europe Telmisartan Consumption Market Share by Application in 2019
Figure 66. Germany Telmisartan Consumption Growth 2015-2020 (MT)
Figure 67. Germany Telmisartan Value Growth 2015-2020 ($ Millions)
Figure 68. France Telmisartan Consumption Growth 2015-2020 (MT)
Figure 69. France Telmisartan Value Growth 2015-2020 ($ Millions)
Figure 70. UK Telmisartan Consumption Growth 2015-2020 (MT)
Figure 71. UK Telmisartan Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Telmisartan Consumption Growth 2015-2020 (MT)
Figure 73. Italy Telmisartan Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Telmisartan Consumption Growth 2015-2020 (MT)
Figure 75. Russia Telmisartan Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Telmisartan Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Telmisartan Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Telmisartan Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Telmisartan Consumption Market Share by Application in 2019
Figure 80. Egypt Telmisartan Consumption Growth 2015-2020 (MT)
Figure 81. Egypt Telmisartan Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Telmisartan Consumption Growth 2015-2020 (MT)
Figure 83. South Africa Telmisartan Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Telmisartan Consumption Growth 2015-2020 (MT)
Figure 85. Israel Telmisartan Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Telmisartan Consumption Growth 2015-2020 (MT)
Figure 87. Turkey Telmisartan Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Telmisartan Consumption Growth 2015-2020 (MT)
Figure 89. GCC Countries Telmisartan Value Growth 2015-2020 ($ Millions)
Figure 90. Global Telmisartan Consumption Growth Rate Forecast (2021-2025) (MT)
Figure 91. Global Telmisartan Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Telmisartan Consumption 2021-2025 (MT)
Figure 93. Americas Telmisartan Value 2021-2025 ($ Millions)
Figure 94. APAC Telmisartan Consumption 2021-2025 (MT)
Figure 95. APAC Telmisartan Value 2021-2025 ($ Millions)
Figure 96. Europe Telmisartan Consumption 2021-2025 (MT)
Figure 97. Europe Telmisartan Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Telmisartan Consumption 2021-2025 (MT)
Figure 99. Middle East & Africa Telmisartan Value 2021-2025 ($ Millions)
Figure 100. United States Telmisartan Consumption 2021-2025 (MT)
Figure 101. United States Telmisartan Value 2021-2025 ($ Millions)
Figure 102. Canada Telmisartan Consumption 2021-2025 (MT)
Figure 103. Canada Telmisartan Value 2021-2025 ($ Millions)
Figure 104. Mexico Telmisartan Consumption 2021-2025 (MT)
Figure 105. Mexico Telmisartan Value 2021-2025 ($ Millions)
Figure 106. Brazil Telmisartan Consumption 2021-2025 (MT)
Figure 107. Brazil Telmisartan Value 2021-2025 ($ Millions)
Figure 108. China Telmisartan Consumption 2021-2025 (MT)
Figure 109. China Telmisartan Value 2021-2025 ($ Millions)
Figure 110. Japan Telmisartan Consumption 2021-2025 (MT)
Figure 111. Japan Telmisartan Value 2021-2025 ($ Millions)
Figure 112. Korea Telmisartan Consumption 2021-2025 (MT)
Figure 113. Korea Telmisartan Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Telmisartan Consumption 2021-2025 (MT)
Figure 115. Southeast Asia Telmisartan Value 2021-2025 ($ Millions)
Figure 116. India Telmisartan Consumption 2021-2025 (MT)
Figure 117. India Telmisartan Value 2021-2025 ($ Millions)
Figure 118. Australia Telmisartan Consumption 2021-2025 (MT)
Figure 119. Australia Telmisartan Value 2021-2025 ($ Millions)
Figure 120. Germany Telmisartan Consumption 2021-2025 (MT)
Figure 121. Germany Telmisartan Value 2021-2025 ($ Millions)
Figure 122. France Telmisartan Consumption 2021-2025 (MT)
Figure 123. France Telmisartan Value 2021-2025 ($ Millions)
Figure 124. UK Telmisartan Consumption 2021-2025 (MT)
Figure 125. UK Telmisartan Value 2021-2025 ($ Millions)
Figure 126. Italy Telmisartan Consumption 2021-2025 (MT)
Figure 127. Italy Telmisartan Value 2021-2025 ($ Millions)
Figure 128. Russia Telmisartan Consumption 2021-2025 (MT)
Figure 129. Russia Telmisartan Value 2021-2025 ($ Millions)
Figure 130. Spain Telmisartan Consumption 2021-2025 (MT)
Figure 131. Spain Telmisartan Value 2021-2025 ($ Millions)
Figure 132. Egypt Telmisartan Consumption 2021-2025 (MT)
Figure 133. Egypt Telmisartan Value 2021-2025 ($ Millions)
Figure 134. South Africa Telmisartan Consumption 2021-2025 (MT)
Figure 135. South Africa Telmisartan Value 2021-2025 ($ Millions)
Figure 136. Israel Telmisartan Consumption 2021-2025 (MT)
Figure 137. Israel Telmisartan Value 2021-2025 ($ Millions)
Figure 138. Turkey Telmisartan Consumption 2021-2025 (MT)
Figure 139. Turkey Telmisartan Value 2021-2025 ($ Millions)
Figure 140. GCC Countries Telmisartan Consumption 2021-2025 (MT)
Figure 141. GCC Countries Telmisartan Value 2021-2025 ($ Millions)
Figure 142. Pfizer Telmisartan Market Share (2018-2020)
Figure 143. Astellas Pharma Inc Telmisartan Market Share (2018-2020)
Figure 144. Teva Telmisartan Market Share (2018-2020)
Figure 145. Novartis Telmisartan Market Share (2018-2020)
Figure 146. Mylan Telmisartan Market Share (2018-2020)
Figure 147. Boehringer Ingelheim Telmisartan Market Share (2018-2020)
Figure 148. Bayer Telmisartan Market Share (2018-2020)
Figure 149. Reddy's Laboratories (UK) Telmisartan Market Share (2018-2020)
Figure 150. GSK Telmisartan Market Share (2018-2020)
Figure 151. Hema Pharmaceuticals Pvt Telmisartan Market Share (2018-2020)
Figure 152. Nippon Boehringer Ingelheim Telmisartan Market Share (2018-2020)
Figure 153. Beijing Wansheng Pharmaceutical Telmisartan Market Share (2018-2020)
Figure 154. Takeda Telmisartan Market Share (2018-2020)
Figure 155. Abbott Telmisartan Market Share (2018-2020)
  • Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......
  • Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......
  • Global Amlodipine Besylate Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115
    The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......
  • Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112
    The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......
  • Captopril API - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100
    The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......
  • Telmisartan - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107
    The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......
  • Global Ambrisentan Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Ambrisentan Market Research Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs